Biosimilars

Latest News

Zymfentra, the First Subcutaneous Infliximab, is Approved by FDA
Zymfentra, the First Subcutaneous Infliximab, is Approved by FDA

October 23rd 2023

Celltrion’s Zymfentra is subcutaneous version of infliximab.

Express Scripts Adds Cyltezo, Hyrimoz and an Unbranded Version of Hyrimoz to Its Main Formulary
Express Scripts Adds Cyltezo, Hyrimoz and an Unbranded Version of Hyrimoz to Its Main Formulary

July 10th 2023

8 Humira Biosimilars Are on the Market
8 Humira Biosimilars Are on the Market

July 4th 2023

  Cyltezo, First Interchangeable Humira Biosimilar, Hits the Market
Cyltezo, First Interchangeable Humira Biosimilar, Hits the Market

July 1st 2023

FDA logo in white on blue background
Hyrimoz, a High-Concentration Humira Biosimilar, Approved by FDA

March 21st 2023

More News

© 2024 MJH Life Sciences

All rights reserved.